|
Neonatal Intensive Care Drug Manual
|
| bet | 539/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Rotavirus Vaccine
Revision Date : 24/9/2019
|
Approved: TC, KOH
|
Alert
|
ORAL ADMINISTRATION ONLY
The first dose of rotavirus vaccine should be given to infants between 6 and 14 weeks chronological age (prior to turning 15 weeks chronological age) and the second dose by 24 weeks of age (prior to turning 25 weeks of age).
The interval between dose 1 and 2 should not be less than 4 weeks.
From July 2017, only Rotarix will be made available under National Immunisation Program in Australia.
Regular look up for any online updates by the Australian Immunisation Register is recommended.
|
Indication
|
Primary immunisation of infants against rotavirus gastroenteritis.
|
Action
|
Live attenuated human rotavirus vaccine that induces protective immunity against the G1P(8) strain and some other non-G1 prevalent strains of rotavirus.
|
Drug Type
|
Vaccine.
|
Trade Name
|
Rotarix
|
Presentation
|
1.5 mL oral suspension in an oral applicator with plunger stopper.
|
Maximum Daily Dose
|
See “Total Cumulative Dose”
|
Total Cumulative Dose
|
Limited data on the safety of administering higher than the recommended dose.
|
Dosage / Interval
|
1.5 mL orally.
|
|
| |
